13 Frequently asked questions This chapter contains the most frequently asked questions about NMPA. Can the OOTB Argus E2B(R3) NMPA profile be used to submit post-marketed and clinical trial ICSRs to NMPA? What should you consider when sending the EDQM terms in Route of Administration and Dosage Formulation elements?